Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Today we distinguish cerebral (acute mountain sickness
AMS
, high altitude cerebral edema HACE) and pulmonal (high altitude
pulmonary edema
HAPE) altitude disorders. Incidence, predisposition and risk factors of all kinds of altitude sickness vary both individually and geographically. For practical reasons the leading symptoms are essential: altitude headache, ataxia and sudden loss of strength. Depending on the severity of symptoms the main emergency measures are: rest, descent or evacuation, warmth. Additional therapeutical measures can be helpful if a sudden evacuation to lower altitudes is delayed: oxygen, portable hyperbaric chamber, ibuprofen/naproxen, nifedipine, dexamethasone. Acetazolamide should not be used as an emergency therapy any more.
...
PMID:[Diagnosis and therapy of acute altitude sickness]. 1096 Sep 57
The most reliable prediction of high altitude tolerance can be derived from the clinical history of previous comparable exposures. Unfortunately, there are no reliable tests for prediction prior to first-time ascents. Although susceptibility to
AMS
is usually associated with a low hypoxic ventilatory response (HVR), there is too much overlap with the range of normal values, which precludes measuring HVR or O(2) saturation during brief hypoxia for reliable identification of susceptibility to
AMS
. A low HVR and an exaggerated rise in pulmonary artery pressure with (prolonged) hypoxia, or exercise in normoxia, are markers of susceptibility to high altitude
pulmonary edema
(HAPE). These tests can not be recommended for routinely determining high altitude tolerance because the prevalence of susceptibility to HAPE is low and because specificity and sensitivity of these tests are not sufficiently established. On the other hand, HAPE may be avoided in susceptible individuals by ascent rates of 300 m per day above an altitude of 2000 m. Since prediction of risk of mountain sickness is difficult, it is important during the physician consultation prior to ascent to consider the altitude profile, the type of ascent, the performance capacity, the history of previous exposures, and the medical infrastructure of the area.
...
PMID:Assessment of high altitude tolerance in healthy individuals. 1144 8